SCHEMBL15568459

SCHEMBL15568459

CC(C)(N=[N+]=[N-])c1ccc(-c2cc3ccc(F)cc3c(=O)[nH]2)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TNKS O95271 12/20 0.48
PARP1 P09874 9/20 0.44
TNKS2 Q9H2K2 8/20 0.44
PARP2 Q9UGN5 1/20 0.38
PARP3 Q9Y6F1 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDM4E B2RXH2 4/20 0.36
KMT2A Q03164 3/20 0.36
ALDH1A1 P00352 3/20 0.36
MEN1 O00255 2/20 0.36
HPGD P15428 2/20 0.36
ERCC1 P07992 1/20 0.35
ERCC4 Q92889 1/20 0.35
PDE2A O00408 1/20 0.34
LMNA P02545 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15568327 0.81 TNKS (0.62) TNKSPARP1TNKS2PARP2PARP3
SCHEMBL15568640 0.81 TNKS (0.57) TNKSPARP1TNKS2PARP2PARP3
Hydrochloric Acid SCHEMBL15566906 0.80 TNKS (0.56) TNKSPARP1TNKS2PARP2PARP3
SCHEMBL15567513 0.76 SMN1; SMN2 (0.61) TNKSPARP1TNKS2SMN1; SMN2KDM4E
SCHEMBL15287405 0.74 TNKS (0.68) TNKSPARP1TNKS2PARP2PARP3
SCHEMBL15568268 0.73 TNKS (0.56) TNKSPARP1TNKS2PARP2PARP3
SCHEMBL15568030 0.73 TNKS (0.68) TNKSPARP1TNKS2PARP2PARP3
SCHEMBL15567682 0.71 TNKS (0.59) TNKSPARP1TNKS2PARP2PARP3
SCHEMBL15569068 0.71 TNKS (0.54) TNKSPARP1TNKS2SMN1; SMN2KDM4E
SCHEMBL16931442 0.70 TNKS (0.53) TNKSPARP1TNKS2SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2882714-B1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-11-13 EP disclosed
US-9376433-B2 (AZA-)isoquinolinone derivatives MERCK PATENT GMBH (DE) 2016-06-28 US disclosed
US-9376433-B2 (AZA-)isoquinolinone derivatives MERCK PATENT GMBH (DE) 2016-06-28 US disclosed
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2015-07-30 US disclosed
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2015-07-30 US disclosed
EP-2882714-A2 (AZA-)ISOQUINOLINONE DERIVATIVES Merck Patent GmbH (DE) 2015-06-17 EP disclosed
WO-2014023390-A2 (AZA-)ISOQUINOLINONE DERIVATIVES MERCK PATENT GMBH (DE) 2014-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210686-A1 (AZA-)ISOQUINOLINONE DERIVATIVES TANK, TNKS, TDP1 TNKS 2/4885PARP1 39/4885TNKS2 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.